Home / Generic medicine
Generic medicine

Bevacizumab

Bevacizumab · ATC L01 · Oncology & immunology · Antineoplastic medicines

Data statusRegistration & price fields require source verification.
10brand families
21registered presentations
8companies
21with current prices
Available dosage forms

Choose a form

Tap a form to filter the brand list
Infusion13 products Injection8 products Clear form filter ×
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.
Print / Save PDFAll 21 presentationsFiltered13 presentations
ShareSend this page
9 brands · 13 presentations
Reset
BrandManufacturerRegistered presentations
ABEVMY1 presentation AGP Limited
100 mg/4 mL Concentrate for solution for infusion 1's 107907 PKR 25,715.622026-07-23 PKR 25,715.62/ vial/unit
Abevmy 4001 presentation AGP Limited
400 mg/16 mL (25 mg/mL) Injection / infusion 1's 107908 PKR 102,238.252026-07-23 PKR 102,238.25/ vial/unit
Avastin1 presentation Roche Pakistan Ltd
400 mg/16 mL Concentrate for solution for infusion 1's 043005 PKR 236,486.522026-07-29 PKR 236,486.52/ vial/unit
BAZUMAB2 presentations Hilton Pharma (Pvt) Limited.
100 mg/4 mL IV infusion 4mlx1's 107941 PKR 23,067.952025-07-01 PKR 5,766.99/ mL
400 mg/16 mL IV infusion 16mlx1's 107942 PKR 91,711.792025-07-01 PKR 5,731.99/ mL
Bevec2 presentations PHARMEVO (PVT) LTD.
100 mg/4 mL (25 mg/mL) Concentrate for infusion 1's 105569 PKR 25,715.632026-07-23 PKR 25,715.63/ vial/unit
400 mg/16 mL (25 mg/mL) Concentrate for solution for infusion 1's 105570 PKR 102,238.252026-07-23 PKR 102,238.25/ vial/unit
Cizumab1 presentation The Searle Company Limited
400 mg/16 mL Concentrate for solution for infusion 1's 105574 PKR 132,267.992026-07-23 PKR 132,267.99/ vial/unit
Cizumab EU3 presentations The Searle Company Limited
100 mg/4 mL Solution for infusion 1's 120492 PKR 25,715.632026-07-23 PKR 25,715.63/ vial/unit
100 mg/4 mL (25 mg/mL) Concentrate for infusion 1's 120492 PKR 25,715.632026-07-23 PKR 25,715.63/ vial/unit
400 mg/16 mL Solution for infusion 1's 120493 PKR 102,238.252026-07-23 PKR 102,238.25/ vial/unit
STIVANT1 presentation CCL Pharmaceuticals (Pvt.) Limited
400 mg/16 mL Concentrate for solution for infusion 1's 107906 PKR 102,238.252026-07-23 PKR 102,238.25/ vial/unit
Zirabev1 presentation Pfizer Pakistan Limited
400 mg/16 mL (25 mg/mL) Injection / infusion 1's 107970 PKR 89,946.122026-07-27 PKR 89,946.12/ vial/unit
Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC L01
MedInfoBase. (2026). Bevacizumab — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/generic/bevacizumab/ ATC L01.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.